Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Cash & Current Investments (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Cash & Current Investments readings, the most recent being $292.7 million for Q4 2025.

  • On a quarterly basis, Cash & Current Investments fell 33.23% to $292.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $292.7 million, a 33.23% decrease, with the full-year FY2025 number at $292.7 million, down 33.23% from a year prior.
  • Cash & Current Investments hit $292.7 million in Q4 2025 for Tandem Diabetes Care, down from $319.1 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $635.4 million in Q1 2022 to a low of $292.7 million in Q4 2025.
  • Median Cash & Current Investments over the past 5 years was $502.7 million (2023), compared with a mean of $494.7 million.
  • Biggest five-year swings in Cash & Current Investments: skyrocketed 220.48% in 2021 and later crashed 33.23% in 2025.
  • Tandem Diabetes Care's Cash & Current Investments stood at $623.8 million in 2021, then fell by 1.11% to $616.9 million in 2022, then dropped by 24.15% to $467.9 million in 2023, then decreased by 6.32% to $438.3 million in 2024, then crashed by 33.23% to $292.7 million in 2025.
  • The last three reported values for Cash & Current Investments were $292.7 million (Q4 2025), $319.1 million (Q3 2025), and $315.4 million (Q2 2025) per Business Quant data.